Reasons to Attend
Conference Highlights
- Case studies from Novo Nordisk and Astrazeneca on successful clinical trial roll out
- Essential insight on resolving issues surrounding patient selection
- Discuss innovative technologies to overcome patient recruitment & retention challenges
- Critical insights on the ever changing regulations for drug approvals
- Strategies for effective communication with key stakeholders for diabetes research and trial implementation
- Top speakers with a wealth of experience in the clinical trials
- Diabetes Research Network highlights matching of diabetes patients with suitable trials
Who will I meet?
- Meet key opinion leaders from the top 3 diabetes pioneers – Sanofi-Aventis, Eli Lilly and Novo Nordisk
- Form new partnerships for both large pharmaceutical companies and small biopharmaceutical companies
- Meet people within the industry, academia and health services to get a 360º perspective
- Get advice from those people who have successfully managed to run clinical trials with minimal drop-outs and excellent recruitment figures
What to look for in this year’s agenda?
- Case study on phase 3 patient recruitment from Novo Nordisk, the industry leaders in diabetes and patient recruitment
- Interactive demonstration of the diabetes matchmaking database designed by the Diabetes Research Network to improve patient recruitment
- Insight into trial design into the emerging markets that will increase patient pools and generate additional revenue
- Maximising your partnerships with CROs, academics, investigators and patients – what does it take?
- Success stories on effective trial integration of cardiovascular endpoint regulations
- Thinking beyond the GLP-1 receptor – looking at new drug targets
- Looking into the Type 1 diabetes trial design and considering how it differs
Back to main site
